Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Targeted DNA/RNA Sequencing Market Report by Technology (NSG, and Others), Workflow (Presequencing, Sequencing, Data Analysis), Application (Human Biomedical Research, Plant and Animal Sciences, Drug Discovery, and Others), Type (DNA-Based Targeted Sequencing, RNA-Based Targeted Sequencing), End User (Hospitals & Clinics, Academic & Research Institutes, Pharma & Biotech Companies), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A12570
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Targeted DNA/RNA Sequencing Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Global Targeted DNA/RNA Sequencing Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 Global Targeted DNA/RNA Sequencing Market - Breakup by Technology
6.1 NGS
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2024-2032)
6.2 Others
6.2.1 Historical and Current Market Trends (2018-2023)
6.2.2 Market Forecast (2024-2032)
6.3 Attractive Investment Proposition by Technology
7 Global Targeted DNA/RNA Sequencing Market - Breakup by Workflow
7.1 Presequencing
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2024-2032)
7.2 Sequencing
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2024-2032)
7.3 Data Analysis
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2024-2032)
7.4 Attractive Investment Proposition by Workflow
8 Global Targeted DNA/RNA Sequencing Market - Breakup by Application
8.1 Human Biomedical Research
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Segmentation
8.1.4 Market Forecast (2024-2032)
8.2 Plant and Animal Sciences
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Segmentation
8.2.4 Market Forecast (2024-2032)
8.3 Drug Discovery
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2018-2023)
8.3.3 Market Segmentation
8.3.4 Market Forecast (2024-2032)
8.4 Others
8.4.1 Historical and Current Market Trends (2018-2023)
8.4.2 Market Forecast (2024-2032)
8.5 Attractive Investment Proposition by Application
9 Global Targeted DNA/RNA Sequencing Market - Breakup by Type
9.1 DNA-based Targeted Sequencing
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2018-2023)
9.1.3 Market Segmentation
9.1.4 Market Forecast (2024-2032)
9.2 RNA-based Targeted Sequencing
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2018-2023)
9.2.3 Market Segmentation
9.2.4 Market Forecast (2024-2032)
9.3 Attractive Investment Proposition by Type
10 Global Targeted DNA/RNA Sequencing Market - Breakup by End User
10 .1 Hospitals & Clinics
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2018-2023)
10.1.3 Market Segmentation
10.1.4 Market Forecast (2024-2032)
10.2 Academic & Research Institutes
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2018-2023)
10.2.3 Market Segmentation
10.2.4 Market Forecast (2024-2032)
10.3 Pharma & Biotech Companies
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2018-2023)
10.3.3 Market Segmentation
10.3.4 Market Forecast (2024-2032)
10.4 Attractive Investment Proposition by End User
11 Global Targeted DNA/RNA Sequencing Market – Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Drivers
11.1.1.2 Historical and Current Market Trends (2018-2023)
11.1.1.3 Market Breakup by Technology
11.1.1.4 Market Breakup by Workflow
11.1.1.5 Market Breakup by Application
11.1.1.6 Market Breakup by Type
11.1.1.7 Market Breakup by End User
11.1.1.8 Key Players
11.1.1.9 Market Forecast (2024-2032)
11.1.2 Canada
11.1.2.1 Market Drivers
11.1.2.2 Historical and Current Market Trends (2018-2023)
11.1.2.3 Market Breakup by Technology
11.1.2.4 Market Breakup by Workflow
11.1.2.5 Market Breakup by Application
11.1.2.6 Market Breakup by Type
11.1.2.7 Market Breakup by End User
11.1.2.8 Key Players
11.1.2.9 Market Forecast (2024-2032)
11.2 Europe
11.2.1 Germany
11.2.1.1 Market Drivers
11.2.1.2 Historical and Current Market Trends (2018-2023)
11.2.1.3 Market Breakup by Technology
11.2.1.4 Market Breakup by Workflow
11.2.1.5 Market Breakup by Application
11.2.1.6 Market Breakup by Type
11.2.1.7 Market Breakup by End User
11.2.1.8 Key Players
11.2.1.9 Market Forecast (2024-2032)
11.2.2 France
11.2.2.1 Market Drivers
11.2.2.2 Historical and Current Market Trends (2018-2023)
11.2.2.3 Market Breakup by Technology
11.2.2.4 Market Breakup by Workflow
11.2.2.5 Market Breakup by Application
11.2.2.6 Market Breakup by Type
11.2.2.7 Market Breakup by End User
11.2.2.7 Key Players
11.2.2.8 Market Forecast (2024-2032)
11.2.3 United Kingdom
11.2.3.1 Market Drivers
11.2.3.2 Historical and Current Market Trends (2018-2023)
11.2.3.3 Market Breakup by Technology
11.2.3.4 Market Breakup by Workflow
11.2.3.5 Market Breakup by Application
11.2.3.6 Market Breakup by Type
11.2.3.7 Market Breakup by End User
11.2.3.8 Key Players
11.2.3.9 Market Forecast (2024-2032)
11.2.4 Italy
11.2.4.1 Market Drivers
11.2.4.2 Historical and Current Market Trends (2018-2023)
11.2.4.3 Market Breakup by Technology
11.2.4.4 Market Breakup by Workflow
11.2.4.5 Market Breakup by Application
11.2.4.6 Market Breakup by Type
11.2.4.7 Market Breakup by End User
11.2.4.8 Key Players
11.2.4.9 Market Forecast (2024-2032)
11.2.5 Spain
11.2.5.1 Market Drivers
11.2.5.2 Historical and Current Market Trends (2018-2023)
11.2.5.3 Market Breakup by Technology
11.2.5.4 Market Breakup by Workflow
11.2.5.5 Market Breakup by Application
11.2.5.6 Market Breakup by Type
11.2.5.7 Market Breakup by End User
11.2.5.8 Key Players
11.2.5.9 Market Forecast (2024-2032)
11.2.6 Others
11.2.6.1 Historical and Current Market Trends (2018-2023)
11.2.6.2 Market Forecast (2024-2032)
11.3 Asia Pacific
11.3.1 China
11.3.1.1 Market Drivers
11.3.1.2 Historical and Current Market Trends (2018-2023)
11.3.1.3 Market Breakup by Technology
11.3.1.4 Market Breakup by Workflow
11.3.1.5 Market Breakup by Application
11.3.1.6 Market Breakup by Type
11.3.1.7 Market Breakup by End User
11.3.1.8 Key Players
11.3.1.9 Market Forecast (2024-2032)
11.3.2 Japan
11.3.2.1 Market Drivers
11.3.2.2 Historical and Current Market Trends (2018-2023)
11.3.2.3 Market Breakup by Technology
11.3.2.4 Market Breakup by Workflow
11.3.2.5 Market Breakup by Application
11.3.2.6 Market Breakup by Type
11.3.2.7 Market Breakup by End User
11.3.2.8 Key Players
11.3.2.9 Market Forecast (2024-2032)
11.3.3 India
11.3.3.1 Market Drivers
11.3.3.2 Historical and Current Market Trends (2018-2023)
11.3.3.3 Market Breakup by Technology
11.3.3.4 Market Breakup by Workflow
11.3.3.5 Market Breakup by Application
11.3.3.6 Market Breakup by Type
11.3.3.7 Market Breakup by End User
11.3.3.8 Key Players
11.3.3.9 Market Forecast (2024-2032)
11.3.4 South Korea
11.3.4.1 Market Drivers
11.3.4.2 Historical and Current Market Trends (2018-2023)
11.3.4.3 Market Breakup by Technology
11.3.4.4 Market Breakup by Workflow
11.3.4.5 Market Breakup by Application
11.3.4.6 Market Breakup by Type
11.3.4.7 Market Breakup by End User
11.3.4.8 Key Players
11.3.4.9 Market Forecast (2024-2032)
11.3.5 Australia
11.3.5.1 Market Drivers
11.3.5.2 Historical and Current Market Trends (2018-2023)
11.3.5.3 Market Breakup by Technology
11.3.5.4 Market Breakup by Workflow
11.3.5.5 Market Breakup by Application
11.3.5.6 Market Breakup by Type
11.3.5.7 Market Breakup by End User
11.3.5.8 Key Players
11.3.5.9 Market Forecast (2024-2032)
11.3.6 Indonesia
11.3.6.1 Market Drivers
11.3.6.2 Historical and Current Market Trends (2018-2023)
11.3.6.3 Market Breakup by Technology
11.3.6.4 Market Breakup by Workflow
11.3.6.5 Market Breakup by Application
11.3.6.6 Market Breakup by Type
11.3.6.7 Market Breakup by End User
11.3.6.8 Key Players
11.3.6.9 Market Forecast (2024-2032)
11.3.7 Others
11.3.7.1 Historical and Current Market Trends (2018-2023)
11.3.7.2 Market Forecast (2024-2032)
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Drivers
11.4.1.2 Historical and Current Market Trends (2018-2023)
11.4.1.3 Market Breakup by Technology
11.4.1.4 Market Breakup by Workflow
11.4.1.5 Market Breakup by Application
11.4.1.6 Market Breakup by Type
11.4.1.7 Market Breakup by End User
11.4.1.8 Key Players
11.4.1.9 Market Forecast (2024-2032)
11.4.2 Mexico
11.4.2.1 Market Drivers
11.4.2.2 Historical and Current Market Trends (2018-2023)
11.4.2.3 Market Breakup by Technology
11.4.2.4 Market Breakup by Workflow
11.4.2.5 Market Breakup by Application
11.4.2.6 Market Breakup by Type
11.4.2.7 Market Breakup by End User
11.4.2.8 Key Players
11.4.2.9 Market Forecast (2024-2032)
11.4.3 Others
11.4.3.1 Historical and Current Market Trends (2018-2023)
11.4.3.2 Market Forecast (2024-2032)
11.5 Middle East and Africa
11.5.1 Market Drivers
11.5.2 Historical and Current Market Trends (2018-2023)
11.5.3 Market Breakup by Technology
11.5.4 Market Breakup by Workflow
11.5.5 Market Breakup by Application
11.5.6 Market Breakup by Type
11.5.7 Market Breakup by End User
11.5.7 Market Breakup by Country
11.5.8 Key Players
11.5.9 Market Forecast (2024-2032)
11.6 Attractive Investment Proposition by Region
12 Global Targeted DNA/RNA Sequencing Market – Competitive Landscape
12.1 Overview
12.2 Market Structure
12.3 Market Share by Key Players
12.4 Market Player Positioning
12.5 Top Winning Strategies
12.6 Competitive Dashboard
12.7 Company Evaluation Quadrant
13 Profiles of Key Players
13.1 Agilent Technologies Inc.
13.1.1 Business Overview
13.1.2 Product Offered
13.1.3 Business Strategies
13.1.4 Financials
13.1.5 SWOT Analysis
13.1.6 Major News and Events
13.2 BGI Group
13.2.1 Business Overview
13.2.2 Product Offered
13.2.3 Business Strategies
13.2.4 Financials
13.2.5 SWOT Analysis
13.2.6 Major News and Events
13.3 Dnastar Inc.
13.3.1 Business Overview
13.3.2 Product Offered
13.3.3 Business Strategies
13.3.4 SWOT Analysis
13.3.5 Major News and Events
13.4 Eurofins Genomics LLC (Eurofins Scientific SE)
13.4.1 Business Overview
13.4.2 Product Offered
13.4.3 Business Strategies
13.4.4 SWOT Analysis
13.4.5 Major News and Events
13.5 F. Hoffmann-La Roche Ltd
13.5.1 Business Overview
13.5.2 Product Offered
13.5.3 Business Strategies
13.5.4 Financials
13.5.5 SWOT Analysis
13.5.6 Major News and Events
13.6 Illumina Inc.
13.6.1 Business Overview
13.6.2 Product Offered
13.6.3 Business Strategies
13.6.4 Financials
13.6.5 SWOT Analysis
13.6.6 Major News and Events
13.7 Integrated DNA Technologies, Inc. (Danaher Corporation)
13.7.1 Business Overview
13.7.2 Product Offered
13.7.3 Business Strategies
13.7.4 SWOT Analysis
13.7.5 Major News and Events
13.8 Macrogen Inc
13.8.1 Business Overview
13.8.2 Product Offered
13.8.3 Business Strategies
13.8.4 Financials
13.8.5 SWOT Analysis
13.8.6 Major News and Events
13.9 Oxford Nanopore Technologies plc
13.9.1 Business Overview
13.9.2 Product Offered
13.9.3 Business Strategies
13.9.4 Financials
13.9.5 SWOT Analysis
13.9.6 Major News and Events
13.10 PacBio
13.10.1 Business Overview
13.10.2 Product Offered
13.10.3 Business Strategies
13.10.4 Financials
13.10.5 SWOT Analysis
13.10.6 Major News and Events
13.11 Pieriandx
13.11.1 Business Overview
13.11.2 Product Offered
13.11.3 Business Strategies
13.11.4 SWOT Analysis
13.11.5 Major News and Events
13.12 QIAGEN N.V.
13.12.1 Business Overview
13.12.2 Product Offered
13.12.3 Business Strategies
13.12.4 Financials
13.12.5 SWOT Analysis
13.12.6 Major News and Events
13.13 Thermo Fisher Scientific Inc.
13.13.1 Business Overview
13.13.2 Product Offered
13.13.3 Business Strategies
13.13.4 Financials
13.13.5 SWOT Analysis
13.13.6 Major News and Events
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
14 Global Targeted DNA/RNA Sequencing Market - Industry Analysis
14.1 Drivers, Restraints, and Opportunities
14.1.1 Overview
14.1.2 Drivers
14.1.3 Restraints
14.1.4 Opportunities
14.1.5 Impact Analysis
14.2 Porters Five Forces Analysis
14.2.1 Overview
14.2.2 Bargaining Power of Buyers
14.2.3 Bargaining Power of Suppliers
14.2.4 Degree of Competition
14.2.5 Threat of New Entrants
14.2.6 Threat of Substitutes
14.3 Value Chain Analysis
15 Strategic Recommendations
16 Appendix
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More